Recent studies have provided compelling evidence regarding IVM’s mechanisms of action in cancer cells, demonstrating its capacity to modulate multiple oncogenic signaling pathways, including Wnt/β-catenin, PI3K/Akt/mTOR, and STAT3. This evidence concerns the gene STAT3 and cancer.